SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+29.99%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$618M
AUM Growth
+$618M
(+15%)
Cap. Flow
-$43.5M
Cap. Flow
% of AUM
-7.05%
Top 10 Holdings %
Top 10 Hldgs %
30.62%
Holding
114
New
21
Increased
23
Reduced
33
Closed
17
Top Buys
| 1 |
Perspective Therapeutics
CATX
|
$14.8M |
| 2 |
CYBN
Cybin
CYBN
|
$10.6M |
| 3 |
BridgeBio Pharma
BBIO
|
$9.39M |
| 4 |
SentinelOne
S
|
$7.86M |
| 5 |
Outlook Therapeutics
OTLK
|
$6.82M |
Top Sells
| 1 |
Nova
NVMI
|
$17.2M |
| 2 |
Astria Therapeutics
ATXS
|
$14.6M |
| 3 |
Cartesian Therapeutics
RNAC
|
$14.2M |
| 4 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
$13.6M |
| 5 |
Tower Semiconductor
TSEM
|
$11.7M |
Sector Composition
| 1 | Healthcare | 75.14% |
| 2 | Technology | 18.02% |
| 3 | Communication Services | 3.09% |
| 4 | Consumer Discretionary | 2.82% |
| 5 | Utilities | 0.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
GSK
GSK
$79.9B
| $4.29M | 0.6% | 100,000 | – | – |
|
52
VistaGen Therapeutics
VTGN
$102M
| $4.27M | 0.6% | 808,550 | – | – |
|
53
Applied Therapeutics
APLT
$71M
| $4.21M | 0.59% | +619,029 | New | +$4.21M |
|
54
Werewolf Therapeutics
HOWL
$59.9M
| $4.06M | 0.57% | 626,810 | – | – |
|
55
Akero Therapeutics
AKRO
$3.74B
| $4.05M | 0.57% | +160,445 | New | +$4.05M |
|
|
SHLT
56
DELISTED
SHL Telemedicine Ltd American Depositary Shares
SHLT
| $3.86M | 0.54% | 632,456 | – | – |
|
57
Pliant Therapeutics
PLRX
$101M
| $3.85M | 0.54% | 258,554 +65,000 | +34% | +$969K |
|
58
ProMIS Neurosciences
PMN
$28M
| $3.5M | 0.49% | 1,834,047 +5 | +0% | +$10 |
|
|
SWTX
59
DELISTED
SpringWorks Therapeutics
SWTX
| $3.46M | 0.49% | 70,269 -100,001 | -59% | -$4.92M |
|
60
Alector
ALEC
$238M
| $3.37M | 0.47% | +560,000 | New | +$3.37M |
|
61
Disc Medicine
IRON
$2.07B
| $3.04M | 0.43% | +48,886 | New | +$3.04M |
|
62
Apple
AAPL
$3.45T
| $3M | 0.42% | +17,500 | New | +$3M |
|
63
Enlight Renewable Energy
ENLT
$3.36B
| $2.86M | 0.4% | 169,280 | – | – |
|
64
SolarEdge
SEDG
$2.01B
| $2.85M | 0.4% | 40,175 -7,825 | -16% | -$555K |
|
65
Rezolute
RZLT
$619M
| $2.54M | 0.36% | 996,710 | – | – |
|
66
Qualcomm
QCOM
$173B
| $2.54M | 0.36% | +15,000 | New | +$2.54M |
|
67
Pfizer
PFE
$141B
| $2.5M | 0.35% | 90,000 | – | – |
|
68
Acadia Pharmaceuticals
ACAD
$4.38B
| $2.31M | 0.32% | +125,000 | New | +$2.31M |
|
|
ELEV
69
DELISTED
Elevation Oncology
ELEV
| $2.21M | 0.31% | 430,000 -470,000 | -52% | -$2.41M |
|
70
Elastic
ESTC
$9.04B
| $2M | 0.28% | +20,000 | New | +$2M |
|
71
Advanced Micro Devices
AMD
$264B
| $1.99M | 0.28% | 11,000 -39,387 | -78% | -$7.11M |
|
72
Compugen
CGEN
$132M
| $1.98M | 0.28% | 769,239 | – | – |
|
73
Nutrien
NTR
$28B
| $1.94M | 0.27% | +35,730 | New | +$1.94M |
|
74
Kezar Life Sciences
KZR
$28.9M
| $1.85M | 0.26% | 2,051,676 | – | – |
|
75
Aprea Therapeutics
APRE
$9.12M
| $1.81M | 0.25% | +270,000 | New | +$1.81M |
|